Target intelligence / Profile preview

Essential amino acid metabolism

Molecular classification
Other
01

Overview

"Essential amino acid metabolism" refers to the set of cellular pathways responsible for the acquisition, utilization, and catabolism of essential amino acids—nutrients that humans cannot synthesize and must obtain from the diet[1][5][7]. These metabolic processes are fundamental for protein synthesis, energy production, biosynthetic reactions, and cell signaling. Disruption of essential amino acid metabolism plays critical roles in health and disease, especially in cancer, where tumor cells often reprogram amino acid uptake and utilization to support rapid proliferation and survival[2][4][6]. Various therapeutic strategies aim to exploit this by depleting specific amino acids or inhibiting transporters and metabolic enzymes, but these interventions carry risks of systemic toxicity and metabolic disturbance[4][6]. As "essential amino acid metabolism" does not identify a unique molecular target, but rather a network of pathways, this entry is not suitable as a canonical therapeutic target.

Other names
Essential amino acid metabolic pathwaysEssential amino acid biosynthesis and degradationEssential amino acid utilization
02

Mechanism of action

Enzymatic depletion of specific amino acids (e.g., asparaginase depleting asparagine, arginine deiminase depleting arginine)[2][4] Inhibition of amino acid transporters to limit nutrient uptake by cancer cells[6][8] Inhibition of metabolic enzymes in tumors, disrupting biosynthesis and energy production[6]

03

Biological functions

Protein synthesisEnergy metabolismRegulation of gene expression (including epigenetic modification)Cell growth and proliferationImmune response
04

Disease associations

CancerMitochondrial diseaseImmunodeficiencyMetabolic disorders
05

Safety considerations

Risk of malnutrition or systemic deficiency if essential amino acid supplies are disruptedOrgan dysfunction due to metabolic imbalancePotential for immune suppression or toxicity with amino acid deprivation therapies[4]
06

Interacting drugs

Enzyme therapies: asparaginase, arginine deiminase

2 more in the full profile.

07

Biomarkers

Expression/activity of specific amino acid transporters (e.g., SLC1A5, SLC7A5, SLC7A11)[6][8]Plasma levels of amino acids (used in metabolic profiling and patient monitoring)[6]

Beyond the preview

Go deeper on Essential amino acid metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Essential amino acid metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call